1887

Abstract

Three human and six bovine parainfluenza virus type 3 (PIV3) strains were examined by the use of 60 monoclonal antibodies (MAbs). Fifty-three MAbs to the human C243 strain were directed against six, four, nine and seven epitopes of the haemagglutinin- neuraminidase (HN), fusion (F), nucleocapsid (N) and matrix proteins, respectively. Seven MAbs to the bovine strain were directed against three epitopes of the HN protein and three epitopes of the F protein. Each strain was characterized in ELISA and immunofluorescence tests with all MAbs and in a haemagglutination inhibition assay with the anti-HN MAbs. There were marked differences between human and bovine viruses, primarily in the HN protein where five epitopes differed. One epitope of the F and one of the N protein also differed. Bovine PIV3 was found to be a homogeneous subtype and distinct from human PIV3.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-7-1577
1990-07-01
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/7/JV0710071577.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-7-1577&mimeType=html&fmt=ahah

References

  1. Abinanti F. R., Chanock R. M., Cook M., Wong D., Warfield M. 1961; Relationship of human and bovine strains of myxovirus para-influenza 3. Proceedings of the Society for Experimental Biology and Medicine 106:466–469
    [Google Scholar]
  2. Bittle J. L., Muir S. 1989 Vaccine Biotechnology 33:27–28
    [Google Scholar]
  3. Chanock R. M., Parrott R. H., Cook K., Andrews B. E., Bell J. A., Reichelderfer T., Kapikian A. Z., Mastrota F. M., Huebner R. J. 1958; Newly recognized myxoviruses from children with respiratory disease. New England Journal of Medicine 258:2072–13
    [Google Scholar]
  4. Chanock R. M., Bell J. A., Parrot R. H. 1961; Natural history of parainfluenza infection. Perspectives in Virology 2:126–139
    [Google Scholar]
  5. Chin J., Magoffin R. L., Shearer L. A., Schieble J. H., Lennette E. H. 1969; Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. American Journal of Epidemiology 89:449–463
    [Google Scholar]
  6. Coelingh K. L., Winter C. C., Murphy B.R.RICE, Kimball P. C., Olmsted R.A. 1986; Conserved epitopes on the hemagglutinin-neuraminidase proteins of human and bovine parainfluenza type 3 virus: nucleotide sequence analysis of variants selected with monoclonal antibodies. Journal of Virology 60:90–96
    [Google Scholar]
  7. Frank G. H., Marshall R. G. 1973; Parainfluenza-3 infection of cattle. Journal of the American Veterinary Medical Association 163:858–860
    [Google Scholar]
  8. Galinski M. S., Mink M. A., Lambert D. M., Wechsler S. L., Pons M. W. 1986; Molecular cloning and sequence analysis of the human parainfluenza 3 virus mRNA encoding the P and C proteins. Virology 155:46–60
    [Google Scholar]
  9. Glezen P. W., Frank A. L., Taber L. H., Kasel J. A. 1984; Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. Journal of Infectious Diseases 150:851–857
    [Google Scholar]
  10. Kingsbury D. W., Bratt M. A., Choppin P. W., Hanson R. P., Hosaka Y., Termeulen V., Norrby E., Plowright W., Rott R., Wunner W. H. 1978; Paramyxoviridae. Intervirology 10:137–152
    [Google Scholar]
  11. Morein B., Sharp M., Sundquist B., Simons K. 1983; Protein subunit vaccines of parainfluenza type 3 virus: immunogenic effect in lambs and mice. Journal of General Virology 64:1557–1569
    [Google Scholar]
  12. Muchmore H. G., Parkinson A. J., Humphries J. E., Scott N. E., Mcintosh D. A., Scott L. V., Cooney M. K., Miles J.A.R. 1981; Persistent parainfluenza virus shedding during isolation at the South Pole. Nature; London: 289187–189
    [Google Scholar]
  13. Ray R., Compans R. W. 1986; Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses. Virology 148:232–236
    [Google Scholar]
  14. Ray R., Brown V. E., Compans R. W. 1985; Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine. Journal of Infectious Diseases 122:1219–1230
    [Google Scholar]
  15. Ray R., Glaze B. J., Compans R. W. 1988a; Role of individual glycoproteins of human PIV type 3 in the induction of a protective immune response. Journal of Virology 62:783–787
    [Google Scholar]
  16. Ray R., Glaze B. J., Moldovenau Z., Compans R. W. 1988b; Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3. Journal oflnfectious Diseases 157:648–654
    [Google Scholar]
  17. Reisinger R. D., Heddleston K. L., Manthel C. A. 1959; A myxovirus (SF-4) associated with shipping fever of cattle. Journal of the American Veterinary Medical Association 135:147–152
    [Google Scholar]
  18. Rydbeck R., Örvell C., Löve A., Norrby E. 1986; Characterization of four parainfluenza virus type 3 proteins by use of monoclonal antibodies. Journal of General Virology 67:1531–1542
    [Google Scholar]
  19. Rydbeck R., Löve A., Örvell C., Norrby E. 1987; Antigenic analysis of human and bovine parainfluenza virus type 3 strains with monoclonal antibodies. Journal of General Virology 68:2153–2160
    [Google Scholar]
  20. Rydbeck R., Löve A., Örvell C. 1988a; Parainfluenza virus type 2 haemagglutinin-neuraminidase glycoprotein characterized with monoclonal antibodies. Journal of General Virology 69:931–935
    [Google Scholar]
  21. Rydbeck R., Löve A., Norrby E. 1988b; Protective effects of monoclonal antibodies against parainfluenza virus type 3-induced brain infection in hamsters. Journal of General Virology 69:1019–1024
    [Google Scholar]
  22. Sanchez A., Banerjee A. K. 1985; Cloning and gene assignment of mRNAs of human parainfluenza virus 3. Virology 147:177–186
    [Google Scholar]
  23. Shibuta H., Kanda T., Adachi A., Yogo Y. 1979; Characterization of bovine parainfluenza virus type 3. Microbiology and Immunology 23:617–628
    [Google Scholar]
  24. Shibuta H., Suzu S., Shioda T. 1986; Differences in bovine parainfluenza 3 virus variants studied by monoclonal antibodies against viral glycoproteins. Virology 155:688–696
    [Google Scholar]
  25. Spriggs M. K., Murphy B., Prince G. A., Olmsted R. A., Collins P. L. 1987; Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity. Journal of Virology 61:3416–3423
    [Google Scholar]
  26. Van Wyke Coelingh K. L., Tierney E. L. 1989; Antigenic and functional organization of human parainfluenza virus type 3 fusion glycoprotein. Journal of Virology 63:375–382
    [Google Scholar]
  27. Van Wyke Coelingh K. L., Winter C., Murphy B. 1985; Antigenic variation in the hemagglutinin-neuraminidase protein of parainfluenza virus type 3. Virology 143:569–582
    [Google Scholar]
  28. Van Wyke Coelingh K. L., Murphy B., Collins P. L., Lebacq-Verheyden A.-M., Battey J. F. 1987; Expression of biologically active and antigenically authentic parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein by a recombinant baculovirus. Virology 160:465–472
    [Google Scholar]
  29. Van Wyke Coelingh K. L., Winter C., Murphy B. 1988a; Nucleotide and deduced amino acid sequence of hemagglutinin- neuraminidase genes of human type 3 parainfluenza virus isolated from 1957 to 1983. Virology 162:137–143
    [Google Scholar]
  30. Van Wyke Coelingh K. L., Winter C. C., Tierney E. L., London W. T., Murphy B. R. 1988b; Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge. Journal of Infectious Diseases 157:655–661
    [Google Scholar]
  31. Wenzel R. P., Mccormick D. P., Beam W. E. 1972; Parainfluenza pneumonia in adults. Journal of the American Medical Association 221:294–295
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-7-1577
Loading
/content/journal/jgv/10.1099/0022-1317-71-7-1577
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error